No evidence of publication bias was detected in nine studies of the ability of serum IGF1 level to predict the OS rate of HCC patients (Begg test, p = 0.083; Egger test, p = 0.103) (Figure 3). The gene discussed is IGF1; the disease is hepatocellular carcinoma.